GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Cyclically Adjusted PS Ratio

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Cyclically Adjusted PS Ratio : 6.61 (As of Jun. 05, 2025)


View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Cyclically Adjusted PS Ratio?

As of today (2025-06-05), Beijing Bohui Innovation Biotechnology Group Co's current share price is ¥5.95. Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 was ¥0.90. Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio for today is 6.61.

The historical rank and industry rank for Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

SZSE:300318' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 5.29   Med: 8.72   Max: 38
Current: 6.52

During the past years, Beijing Bohui Innovation Biotechnology Group Co's highest Cyclically Adjusted PS Ratio was 38.00. The lowest was 5.29. And the median was 8.72.

SZSE:300318's Cyclically Adjusted PS Ratio is ranked worse than
54.73% of 497 companies
in the Biotechnology industry
Industry Median: 5.63 vs SZSE:300318: 6.52

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Beijing Bohui Innovation Biotechnology Group Co's adjusted revenue per share data for the three months ended in Mar. 2025 was ¥0.249. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ¥0.90 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Beijing Bohui Innovation Biotechnology Group Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Cyclically Adjusted PS Ratio Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 21.01 15.88 8.40 7.78 6.47

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.45 5.72 6.90 6.47 6.10

Competitive Comparison of Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio falls into.


;
;

Beijing Bohui Innovation Biotechnology Group Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=5.95/0.90
=6.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Beijing Bohui Innovation Biotechnology Group Co's adjusted Revenue per Share data for the three months ended in Mar. 2025 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.249/115.1156*115.1156
=0.249

Current CPI (Mar. 2025) = 115.1156.

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201506 0.200 99.500 0.231
201509 0.188 100.500 0.215
201512 0.327 100.600 0.374
201603 0.158 102.200 0.178
201606 0.106 101.400 0.120
201609 0.106 102.400 0.119
201612 0.150 102.600 0.168
201703 0.102 103.200 0.114
201706 0.133 103.100 0.149
201709 0.141 104.100 0.156
201712 0.167 104.500 0.184
201803 0.157 105.300 0.172
201806 0.179 104.900 0.196
201809 0.197 106.600 0.213
201812 0.227 106.500 0.245
201903 0.165 107.700 0.176
201906 0.202 107.700 0.216
201909 0.205 109.800 0.215
201912 0.197 111.200 0.204
202003 0.171 112.300 0.175
202006 0.160 110.400 0.167
202009 0.279 111.700 0.288
202012 0.292 111.500 0.301
202103 0.195 112.662 0.199
202106 0.231 111.769 0.238
202109 0.225 112.215 0.231
202112 0.224 113.108 0.228
202203 0.215 114.335 0.216
202206 0.254 114.558 0.255
202209 0.262 115.339 0.261
202212 0.243 115.116 0.243
202303 0.308 115.116 0.308
202306 0.342 114.558 0.344
202309 0.337 115.339 0.336
202312 0.293 114.781 0.294
202403 0.321 115.227 0.321
202406 0.275 114.781 0.276
202409 0.194 115.785 0.193
202412 0.251 114.893 0.251
202503 0.249 115.116 0.249

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Beijing Bohui Innovation Biotechnology Group Co  (SZSE:300318) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Beijing Bohui Innovation Biotechnology Group Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Beijing Bohui Innovation Biotechnology Group Co Business Description

Traded in Other Exchanges
N/A
Address
Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097
Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.
Executives
Niu Shu Hui Executives
Di Xiao Feng Director
Yang Qi Director
Lu Xin Qun Directors, executives
Zhang Lei Director
Wan Zhang Geng Executives
Song Rui Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines